Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Papers
(The TQCC of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis63
The human gut microbiota in people with amyotrophic lateral sclerosis44
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS42
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study39
An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice32
Focus on the heterogeneity of amyotrophic lateral sclerosis31
Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy31
An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials28
Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls28
Increased risk and early onset of ALS in professional players from Italian Soccer Teams28
Understanding the needs of people with ALS: a national survey of patients and caregivers27
Blended psychosocial support for partners of patients with ALS and PMA: results of a randomized controlled trial26
Progression and survival of patients with motor neuron disease relative to their fecal microbiota25
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience23
A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis20
Prevalence of amyotrophic lateral sclerosis (ALS), United States, 201619
Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis19
Neuroimaging in primary lateral sclerosis19
The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential18
TDP-43 pathology in primary lateral sclerosis18
TRICALS: creating a highway toward a cure17
Grief, depression, and anxiety in bereaved caregivers of people with motor neurone disease: a population-based national study17
Incidence of amyotrophic lateral sclerosis in the United States, 2014–201617
Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients16
Disorders of sleep and wakefulness in amyotrophic lateral sclerosis (ALS): a systematic review16
A multi-center study of neurofilament assay reliability and inter-laboratory variability15
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic15
Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 201715
Differentiating needs of informal caregivers of individuals with ALS across the caregiving course: a systematic review15
Psychological interventions for people with motor neuron disease: a scoping review14
Who cares for the bereaved? A national survey of family caregivers of people with motor neurone disease14
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study14
Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study14
Prevalence of pain in amyotrophic lateral sclerosis: a systematic review and meta-analysis13
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches13
Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis13
Trauma and amyotrophic lateral sclerosis: a systematic review and meta-analysis12
An online non-meditative mindfulness intervention for people with ALS and their caregivers: a randomized controlled trial12
Estimation of forced vital capacity using speech acoustics in patients with ALS12
Increased synthesis of pro-inflammatory cytokines in C9ORF72 patients12
Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis11
Cognitive reserve is associated with altered clinical expression in amyotrophic lateral sclerosis11
A prospective study on split-hand index as a biomarker for the diagnosis of amyotrophic lateral sclerosis11
Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France11
Simultaneous ALS and SCA2 associated with an intermediate-length ATXN2 CAG-repeat expansion11
Genetics of frontotemporal dementia in China11
The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis11
Pulmonary function decline in amyotrophic lateral sclerosis11
Genetics of primary lateral sclerosis10
The reading the mind in the eyes test short form (A & B): validation and outcomes in an amyotrophic lateral sclerosis cohort10
Neurophysiological features of primary lateral sclerosis10
Motor Neuron Disease Register for England, Wales and Northern Ireland—an analysis of incidence in England10
Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. study10
UK case control study of smoking and risk of amyotrophic lateral sclerosis10
Urinary p75ECD levels in patients with amyotrophic lateral sclerosis: a meta-analysis9
Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes9
Genetic testing for amyotrophic lateral sclerosis in Canada – an assessment of current practices9
Natural history and clinical features of ALS in Malaysia9
The diagnostic value of the Italian version of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS)9
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale9
The clinical spectrum of primary lateral sclerosis9
Neuropathology of primary lateral sclerosis9
Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability9
Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis8
A de novo c.1509dupA:p.R503fs mutation of FUS: report of a girl with sporadic juvenile amyotrophic lateral sclerosis8
Chorea is a pleiotropic clinical feature of mutated fused-in-sarcoma in amyotrophic lateral sclerosis8
Mutations of DNAJC7 are rare in Chinese amyotrophic lateral sclerosis patients8
Muscle MRI in motor neuron diseases: a systematic review8
Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis8
Human endogenous retrovirus K (HERV-K) env in neuronal extracellular vesicles: a new biomarker of motor neuron disease8
Levels of clusterin, CD5L, ficolin-3, and gelsolin in ALS patients and controls8
Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study8
Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: a meta-analysis study8
Dyslipidemia in patients with amyotrophic lateral sclerosis – a case control retrospective study8
Case-control study in ALS using the National ALS Registry: lead and agricultural chemicals are potential risk factors8
Novel FUS mutation Y526F causing rapidly progressive familial amyotrophic lateral sclerosis8
Epidemiological and genetic features of amyotrophic lateral sclerosis in Latin America and the Caribbean: a systematic review8
Arabic adaptation and validation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R): Egyptian study7
Motor neuron disease beginning with frontotemporal dementia: clinical features and progression7
Gastrointestinal biopsies and amyotrophic lateral sclerosis – results from a cohort study of 1.1 million individuals7
Clinical characteristics in young-adult ALS – results from a Portuguese cohort study7
Mouth occlusion pressure at 100ms (P0.1) as a respiratory biomarker in amyotrophic lateral sclerosis7
Respiratory onset in amyotrophic lateral sclerosis: clinical features and spreading pattern7
The path to diagnosis in ALS: delay, referrals, alternate diagnoses, and clinical progression7
History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010–20187
Improvements in the multidisciplinary care are beneficial for survival in amyotrophic lateral sclerosis (ALS): experience from a tertiary ALS center7
Dysfunction of the left angular gyrus may be associated with writing errors in ALS7
Genotype-phenotype correlations of KIF5A stalk domain variants7
Reliable change indices for the Italian Edinburgh Cognitive and Behavioral ALS Screen (ECAS)7
Cardiac troponin T is elevated and increases longitudinally in ALS patients7
Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic6
Problem-focused coping underlying lower caregiver burden in ALS-FTD: implications for caregiver intervention6
Three different short-interval intracortical inhibition methods in early diagnosis of amyotrophic lateral sclerosis6
Validation of the Italian version of self-administered ALSFRS-R scale6
A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment6
Comparison of the ability of the King’s and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis6
Spectroscopic markers of neurodegeneration in the mesial prefrontal cortex predict survival in ALS6
Elevated plasma levels of D-serine in some patients with amyotrophic lateral sclerosis6
The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients6
The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia6
Percutaneous gastrostomy in amyotrophic lateral sclerosis: a review6
ALSUntangled #64: butyrates6
Characterization of the amyotrophic lateral sclerosis-linked P56S mutation of the VAPB gene in Southern Brazil6
Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age–sex interaction and spatial–temporal variability6
Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures6
What is amyotrophic lateral sclerosis prevalence?6
Persian adaptation of Edinburgh Cognitive and Behavioural Screen (ECAS)6
Cerebellar degeneration in primary lateral sclerosis: an under-recognized facet of PLS6
The epidemiology of amyotrophic lateral sclerosis in Moscow (Russia)6
0.12378811836243